Tender Offer - Turnstone Biologics Corp.

Form Type: SC TO-C

Filing Date: 2025-06-27

Corporate Action: Tender-offer

Type: New

Accession Number: 000119312525149747

Filing Summary: On June 27, 2025, Turnstone Biologics Corp. filed a Schedule TO-C form regarding a proposed tender offer initiated by XOMA Royalty Corporation. The tender offer aims to acquire all outstanding shares of Turnstone's common stock at a specified price. This filing relates to preliminary communications made before the tender offer's commencement. According to the merger agreement dated June 26, 2025, the acquisition involves XOMA Royalty Corporation considered as the Parent and XRA 3 Corp., a wholly owned subsidiary, as part of the acquisition structure. The document emphasizes the nature of forward-looking statements regarding the offer, including risks and uncertainties that might impact completion and stockholder payouts. Important details about the tender offer process are also mentioned, as well as disclaimers regarding the forward-looking statements.